APA (7th ed.) Citation

Kucharczuk, J., Kasprzak, H., & Gawęcki, M. (2025). Switching from Aflibercept to Faricimab in the Treatment of Neovascular Age-Related Macular Degeneration: Short-Term Results from Real-Life Study. Journal of Clinical Medicine, 14(20), 7345. https://doi.org/10.3390/jcm14207345

Chicago Style (17th ed.) Citation

Kucharczuk, Jan, Hubert Kasprzak, and Maciej Gawęcki. "Switching from Aflibercept to Faricimab in the Treatment of Neovascular Age-Related Macular Degeneration: Short-Term Results from Real-Life Study." Journal of Clinical Medicine 14, no. 20 (2025): 7345. https://doi.org/10.3390/jcm14207345.

MLA (9th ed.) Citation

Kucharczuk, Jan, et al. "Switching from Aflibercept to Faricimab in the Treatment of Neovascular Age-Related Macular Degeneration: Short-Term Results from Real-Life Study." Journal of Clinical Medicine, vol. 14, no. 20, 2025, p. 7345, https://doi.org/10.3390/jcm14207345.